Russell D Cohen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Russell D Cohen

Showing results (61-70 of 142) with videos related to

Pageof 15

Sort By:

Inflammatory Bowel Diseases|October 18, 2013

Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's diseaseAtsushi Sakuraba, Maria L Annunziata, Russell D Cohen, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015

Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab TherapyEmanuelle Bellaguarda, Kian Keyashian, Joel Pekow, et al.

Archives of Pathology & Laboratory Medicine|January 23, 2004

Collagenous gastritis: an unusual association with profound weight lossHanlin L Wang, Amit G Shah, Lisa M Yerian, et al.

Inflammatory Bowel Diseases|January 30, 2023

Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel DiseaseDavid K Choi, Nathaniel A Cohen, Tenzin Choden, et al.

BMC Gastroenterology|December 6, 2022

Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitisVipul Jairath, Russell D Cohen, Edward V Loftus, et al.

Gastrointestinal Endoscopy|April 25, 2007

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?David T Rubin, Jami A Rothe, Jeremy T Hetzel, et al.

Journal of Clinical Gastroenterology|July 21, 2017

Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel DiseasesAndres J Yarur, Bilal Gondal, Ayal Hirsch, et al.

Digestive Diseases and Sciences|November 20, 2025

Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case SeriesYusuke Miyatani, David Choi, Andrew I Aronsohn, et al.

Gastroenterology|May 31, 2015

Ulcerative Colitis Care PathwayThemistocles Dassopoulos, Russell D Cohen, Ellen J Scherl, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 6, 2017

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to VaccinesDawn B Beaulieu, Ashwin N Ananthakrishnan, Christopher Martin, et al.

Pageof 15

Search research articles

Showing results (61-70 of 142) with videos related to

Sort By:

Pageof 15

Inflammatory Bowel Diseases|October 18, 2013

Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's diseaseAtsushi Sakuraba, Maria L Annunziata, Russell D Cohen, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2015

Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab TherapyEmanuelle Bellaguarda, Kian Keyashian, Joel Pekow, et al.

Archives of Pathology & Laboratory Medicine|January 23, 2004

Collagenous gastritis: an unusual association with profound weight lossHanlin L Wang, Amit G Shah, Lisa M Yerian, et al.

Inflammatory Bowel Diseases|January 30, 2023

Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel DiseaseDavid K Choi, Nathaniel A Cohen, Tenzin Choden, et al.

BMC Gastroenterology|December 6, 2022

Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitisVipul Jairath, Russell D Cohen, Edward V Loftus, et al.

Gastrointestinal Endoscopy|April 25, 2007

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?David T Rubin, Jami A Rothe, Jeremy T Hetzel, et al.

Journal of Clinical Gastroenterology|July 21, 2017

Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel DiseasesAndres J Yarur, Bilal Gondal, Ayal Hirsch, et al.

Digestive Diseases and Sciences|November 20, 2025

Safety and Efficacy of Upadacitinib in Patients with Inflammatory Bowel Disease After Liver Transplantation: A Case SeriesYusuke Miyatani, David Choi, Andrew I Aronsohn, et al.

Gastroenterology|May 31, 2015

Ulcerative Colitis Care PathwayThemistocles Dassopoulos, Russell D Cohen, Ellen J Scherl, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 6, 2017

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to VaccinesDawn B Beaulieu, Ashwin N Ananthakrishnan, Christopher Martin, et al.

Pageof 15